Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities
Authors:
- Zhe JiangZJZhe Jiang
- Michelle S. AllkanjariMAMichelle S. Allkanjari
- Philip E. D. ChungPCPhilip E. D. Chung
- Hanna TranHTHanna Tran
- Ronak Ghanbari-AzarnierRGRonak Ghanbari-Azarnier
- Dong-Yu WangDWDong-Yu Wang
- Daniel J. LinDLDaniel J. Lin
- Jung Yeon MinJMJung Yeon Min
- Yaacov Ben-DavidYBYaacov Ben-David
- Eldad ZacksenhausEldad Zacksenhaus
Open Access
Abstract
Pineoblastoma (PB) is a rare yet lethal pediatric brain cancer of the pineal gland, a small endocrine organ that secretes melatonin to regulate the circadian rhythm. For PB patients ≤5 years of age, the overall survival rate is approximately 15%; metastatic PB is incurable. Standard treatment, including surgical resection, radiation, and systemic chemotherapy, improves survival but compromises neurocognitive function. A better understanding of the disease and the generation of preclinical models may enable re-evaluation of previous clinical trials, development of precision therapeutic strategies and improve patient outcome. Over the past 5 years, PB has been recognized to include several major subtypes driven by (i) loss of microRNA processing factors DICER and DROSHA characterized by a relatively good prognosis; (ii) loss of the retinoblastoma tumor suppressor RB1; and (iii) amplification or induction of the cMYC protooncogene, with the latter two subtypes exhibiting exceedingly poor prognosis. Recently, mouse models for the major PB subtypes (RB1-, DICER1- and DROSHA-) except MYC- have been established. This progress, including better understanding of the disease, cell of origin, tumor progression, role of autophagy, and targetable vulnerabilities, holds promise for novel therapeutic strategies to combat each subtype of this lethal childhood malignancy.Keywords
Funding Information
- Canadian Institute of Health Research (CIHR)
This publication has 150 references indexed in Scilit:
- DICER1 syndrome: Approach to testing and management at a large pediatric tertiary care centerPediatric Blood & Cancer, 2017
- Germ-line and somatic DICER1 mutations in pineoblastomaActa Neuropathologica, 2014
- In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studiesCellular and Molecular Life Sciences, 2014
- The long‐term postsurgical prognosis of patients with pineoblastomaCancer, 2011
- Multifaceted Chemotherapy for Trilateral RetinoblastomaArchives of Ophthalmology (1950), 2011
- One hit, two hits, three hits, more? Genomic changes in the development of retinoblastomaGenes, Chromosomes and Cancer, 2007
- Transgenic mice for Cre‐inducible overexpression of the oncogenes c‐MYC and Pim‐1 in multiple tissuesGenesis, 2006
- Pinealoblastomas in childrenChild's Nervous System, 2006
- Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosisBrain Tumor Pathology, 1999
- The separation of pineocytoma from pineoblastomaCancer, 1980